Enhancement of LymphangiogenesisIn Vitrovia the Regulations of HIF-1Expression and Nuclear Translocation by Deoxyshikonin
Authors:
Open Access
- 1 January 2013
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2013, 1-11
Abstract
The objectives of this study were to determine the effects of deoxyshikonin on lymphangiogenesis. Deoxyshikonin enhanced the ability of human dermal lymphatic microvascular endothelial cells (HMVEC-dLy) to undergo time-dependentin vitrocord formation. Interestingly, an opposite result was observed in cells treated with shikonin. The increased cord formation ability following deoxyshikonin treatment correlated with increased VEGF-C mRNA expression to higher levels than seen for VEGF-A and VEGF-D mRNA expression. We also found that deoxyshikonin regulated cord formation of HMVEC-dLy by increasing the HIF-1αmRNA level, HIF-1αprotein level, and the accumulation of HIF-1αin the nucleus. Knockdown of the HIF-1αgene by transfection with siHIF-1αdecreased VEGF-C mRNA expression and cord formation ability in HMVEC-dLy. Deoxyshikonin treatment could not recover VEGF-C mRNA expression and cord formation ability in HIF-1αknockdown cells. This indicated that deoxyshikonin induction of VEGF-C mRNA expression and cord formation in HMVEC-dLy on Matrigel occurred mainly via HIF-1αregulation. We also found that deoxyshikonin promoted wound healingin vitroby the induction of HMVEC-dLy migration into the wound gap. This study describes a new effect of deoxyshikonin, namely, the promotion of cord formation by human endothelial cells via the regulation of HIF-1α. The findings suggest that deoxyshikonin may be a new drug candidate for wound healing and treatment of lymphatic diseases.Keywords
Funding Information
- Japan Society for the Promotion of Science (22501042)
This publication has 32 references indexed in Scilit:
- In vitro and in vivo anticancer effects of Lithospermum erythrorhizon extract on B16F10 murine melanomaJournal of Ethnopharmacology, 2012
- Conditional hypoxia inducible factor-1α induction in embryonic pulmonary epithelium impairs maturation and augments lymphangiogenesisDevelopmental Biology, 2012
- Functional regulation of HIF‐1α under normoxia—is there more than post‐translational regulation?Journal of Cellular Physiology, 2011
- HIF‐1α: coordinates lymphangiogenesis during wound healing and in response to inflammationThe FASEB Journal, 2011
- The Lymphatic System in Health and DiseaseLymphatic Research and Biology, 2008
- The interplay between MYC and HIF in cancerNature Reviews Cancer, 2008
- Decreased Macrophage Number and Activation Lead to Reduced Lymphatic Vessel Formation and Contribute to Impaired Diabetic Wound HealingThe American Journal of Pathology, 2007
- Hypoxia inducible factor-1α correlates with VEGF-C expression and lymphangiogenesis in breast cancerBreast Cancer Research and Treatment, 2006
- Cellular pharmacology studies of shikonin derivativesPhytotherapy Research, 2002
- An Autocrine Loop Mediates Expression of Vascular Endothelial Growth Factor in Human Dermal Microvascular Endothelial CellsJournal of Investigative Dermatology, 2001